Picture 1 of 1
The Cure in the Code: How 20th Century Law is Undermining 21st Century M - GOOD
Condition:
3 available
Price:
US $6.88
ApproximatelyC $9.43
- Buy It NowThe Cure in the Code: How 20th Century Law is Undermining 21st Century M - GOOD
Shipping:
Located in: Montgomery, Illinois, United States
Delivery:
Estimated between Thu, May 9 and Tue, May 14 to 43230
Returns:
Payments:
Shop with confidence
Seller information
- 98.1% positive feedback
Registered as a Business Seller
Seller assumes all responsibility for this listing.
eBay item number:256436568841
Item specifics
- Condition
- Brand
- Unbranded
- MPN
- Does not apply
- ISBN
- 9780465050680
- Book Title
- Cure in the Code : How 20th Century Law Is Undermining 21st Century Medicine
- Item Length
- 9.5in
- Publisher
- Basic Books
- Publication Year
- 2013
- Format
- Hardcover
- Language
- English
- Item Height
- 1in
- Genre
- Technology & Engineering, Law, Science, Medical
- Topic
- Biotechnology, Medical Law & Legislation, Health, Life Sciences / Genetics & Genomics, Biomedical
- Item Width
- 6.3in
- Item Weight
- 18 Oz
- Number of Pages
- 304 Pages
About this product
Product Information
Never before have two revolutions with so much potential to save and prolong human life occurred simultaneously. The converging, synergistic power of the biochemical and digital revolutions now allows us to read every letter of life's code, create precisely targeted drugs to control it, and tailor their use to individual patients. Cancer, diabetes, Alzheimer's and countless other killers can be vanquished -- if we make full use of the tools of modern drug design and allow doctors the use of modern data gathering and analytical tools when prescribing drugs to their patients. But Washington stands in the way, clinging to outdated drug-approval protocols developed decades ago during medicine's long battle with the infectious epidemics of the past. Peter Huber, an expert in science, technology, and public policy, demonstrates why Washington's one-size-fits-all drug policies can't deal with diseases rooted in the complex molecular diversity of human bodies. Washington is ill-equipped to handle the torrents of data that now propel the advance of molecular medicine and is reluctant to embrace the statistical methods of the digital age that can. Obsolete economic policies, often rationalized as cost-saving measures, stifle innovation and suppress investment in the medicine that can provide the best cures at the lowest cost. In the 1980s, an AIDS diagnosis was a death sentence, until the FDA loosened its throttling grip and began streamlining and accelerating approval of life-saving drugs. The Cure in the Code shows patients, doctors, investors, and policy makers what we must now do to capture the full life-saving and cost-saving potential of the revolution in molecular medicine. America has to choose. At stake for America is the power to lead the world in mastering the most free, fecund, competitive, dynamic, and intelligent natural resource on the planet -- the molecular code that spawns human life and controls our health.
Product Identifiers
Publisher
Basic Books
ISBN-10
0465050689
ISBN-13
9780465050680
eBay Product ID (ePID)
160092756
Product Key Features
Book Title
Cure in the Code : How 20th Century Law Is Undermining 21st Century Medicine
Format
Hardcover
Language
English
Topic
Biotechnology, Medical Law & Legislation, Health, Life Sciences / Genetics & Genomics, Biomedical
Publication Year
2013
Genre
Technology & Engineering, Law, Science, Medical
Number of Pages
304 Pages
Dimensions
Item Length
9.5in
Item Height
1in
Item Width
6.3in
Item Weight
18 Oz
Additional Product Features
Lc Classification Number
Rs380.H83 2013
Reviews
Our ability to read the genetic code heralds a transformation of modern medicine. Yet many potential medical miracles remain throttled….[Huber's] ardor for invigorating pharmaceutical progress is apparent on every page." — Booklist "Intriguing." — Kirkus Reviews A provocative, optimistic look at modern medicine… Huber's challenge is sure to spark controversy as the U.S. adapts to the Affordable Care Act." — Publishers Weekly A must read for physicians, patients, biotech investors, and healthcare politicians, The Cure in the Code is the most important policy book of the decade, and it could only have been written by Peter Huber, a polymathic master of both the deadly menace and huge promise of bioscience, and scathing critic of the blindness of healthcare bureaucracy." — George Gilder, author of Knowledge and Power: The Information Theory of Capitalism A thoughtful and compelling account of how the federal government's current regulatory science is not only outdated, but risks hampering scientific efforts to combat diseases at the molecular level. Marshaling insights from medicine, law, and economics, Huber makes an urgent case for how to improve the drug and therapy regulatory system to better equip physicians with innovative treatments that meet critical patient needs." — Tom Coburn, M.D., United States Senator from Oklahoma Peter Huber is one of only a handful of public intellectuals with a deep understanding of science, economics, and the law. In The Cure in the Code , Huber explains scientific advances in molecular biology and genetic engineering, the economics of pharmaceuticals and medicine, and the intersection of all of these with FDA law and policy. This is a key guide to the promise of personalized medicine—personalized down to the genetic level—and also to the policies that can deliver that promise." — Alex Tabarrok, Professor and Bartley J. Madden Chair in Economics, George Mason University Peter Huber has eloquently portrayed the transition of medicine from art to science in the 21st century. But The Cure in the Code offers much more as he illuminates the changes that must occur in the research, regulatory, reimbursement ecosystem if the promise of cures is to be fulfilled." — Andrew von Eschenbach, Commissioner of the U.S. Food and Drug Administration (2005-2009), "[Huber is] one of the few men walking the Earth who could write a book about FDA reform that is not only profitable but pleasurable to read. The book is exciting, in that it suggests possibilities for significant improvements in our ability to treat terrifying diseases in the near future; but it is also depressing, because its sophisticated analysis - in flying so far above regulation-deregulation and government-market binaries that dominate so many of our policy debates - cannot help but draw one's attention to the intellectual poverty of Washington's practically pre-Copernican approach to important policy decisions.... The book is sprinkled liberally with sentences that are thought-provoking gems, each worthy of an essay of its own.... [A] very rich book." -- National Review "Our ability to read the genetic code heralds a transformation of modern medicine. Yet many potential medical miracles remain throttled....[Huber's] ardor for invigorating pharmaceutical progress is apparent on every page." -- Booklist "Intriguing." -- Kirkus Reviews "A provocative, optimistic look at modern medicine... Huber's challenge is sure to spark controversy as the U.S. adapts to the Affordable Care Act." -- Publishers Weekly, [An] urgent, compelling account of how 21st-century medicine is being hampered by a regulatory regime built for the science of the 20th century." — Wall Street Journal Our ability to read the genetic code heralds a transformation of modern medicine. Yet many potential medical miracles remain throttled….[Huber's] ardor for invigorating pharmaceutical progress is apparent on every page." — Booklist Intriguing." — Kirkus Reviews A provocative, optimistic look at modern medicine… Huber's challenge is sure to spark controversy as the U.S. adapts to the Affordable Care Act." — Publishers Weekly A must read for physicians, patients, biotech investors, and healthcare politicians, The Cure in the Code is the most important policy book of the decade, and it could only have been written by Peter Huber, a polymathic master of both the deadly menace and huge promise of bioscience, and scathing critic of the blindness of healthcare bureaucracy." — George Gilder, author of Knowledge and Power: The Information Theory of Capitalism A thoughtful and compelling account of how the federal government's current regulatory science is not only outdated, but risks hampering scientific efforts to combat diseases at the molecular level. Marshaling insights from medicine, law, and economics, Huber makes an urgent case for how to improve the drug and therapy regulatory system to better equip physicians with innovative treatments that meet critical patient needs." — Tom Coburn, M.D., United States Senator from Oklahoma Peter Huber is one of only a handful of public intellectuals with a deep understanding of science, economics, and the law. In The Cure in the Code , Huber explains scientific advances in molecular biology and genetic engineering, the economics of pharmaceuticals and medicine, and the intersection of all of these with FDA law and policy. This is a key guide to the promise of personalized medicine—personalized down to the genetic level—and also to the policies that can deliver that promise." — Alex Tabarrok, Professor and Bartley J. Madden Chair in Economics, George Mason University Peter Huber has eloquently portrayed the transition of medicine from art to science in the 21st century. But The Cure in the Code offers much more as he illuminates the changes that must occur in the research, regulatory, reimbursement ecosystem if the promise of cures is to be fulfilled." — Andrew von Eschenbach, Commissioner of the U.S. Food and Drug Administration (2005-2009), "[An] urgent, compelling account of how 21st-century medicine is being hampered by a regulatory regime built for the science of the 20th century." -- Wall Street Journal "[An] exciting and authoritative review of accelerating advances in personalized medicine." -- Barron's "Spotlighting an area where federal laws and regulations lag far behind technological innovation, the author, a Manhattan Institute senior fellow, maintains that medicine's rapidly developing capacity to decode individual human genomes and tailor patients' treatments accordingly - as with breast cancer - is being hindered by...'outdated drug-approval protocols developed decades ago during medicine's long battle with the infectious epidemics of the past.'" -- Pittsburgh Tribune-Review, "A thoughtful and compelling account of how the federal government's current regulatory science is not only outdated, but risks hampering scientific efforts to combat diseases at the molecular level. Marshaling insights from medicine, law, and economics, Huber makes an urgent case for how to improve the drug and therapy regulatory system to better equip physicians with innovative treatments that meet critical patient needs." -- Tom Coburn, M.D., United States Senator from Oklahoma "Peter Huber is one of only a handful of public intellectuals with a deep understanding of science, economics, and the law. In The Cure in the Code , Huber explains scientific advances in molecular biology and genetic engineering, the economics of pharmaceuticals and medicine, and the intersection of all of these with FDA law and policy. This is a key guide to the promise of personalized medicine--personalized down to the genetic level--and also to the policies that can deliver that promise." -- Alex Tabarrok, Professor and Bartley J. Madden Chair in Economics, George Mason University "Peter Huber has eloquently portrayed the transition of medicine from art to science in the 21st century. But The Cure in the Code offers much more as he illuminates the changes that must occur in the research, regulatory, reimbursement ecosystem if the promise of cures is to be fulfilled." -- Andrew von Eschenbach, Commissioner of the U.S. Food and Drug Administration (2005-2009), "[An] urgent, compelling account of how 21st-century medicine is being hampered by a regulatory regime built for the science of the 20th century." -- Wall Street Journal "[An] exciting and authoritative review of accelerating advances in personalized medicine." -- Barron's "Spotlighting an area where federal laws and regulations lag far behind technological innovation, the author, a Manhattan Institute senior fellow, maintains that medicine's rapidly developing capacity to decode individual human genomes and tailor patients' treatments accordingly - as with breast cancer - is being hindered by...''outdated drug-approval protocols developed decades ago during medicine's long battle with the infectious epidemics of the past.'" -- Pittsburgh Tribune-Review "[Huber is] one of the few men walking the Earth who could write a book about FDA reform that is not only profitable but pleasurable to read. The book is exciting, in that it suggests possibilities for significant improvements in our ability to treat terrifying diseases in the near future; but it is also depressing, because its sophisticated analysis - in flying so far above regulation-deregulation and government-market binaries that dominate so many of our policy debates - cannot help but draw one's attention to the intellectual poverty of Washington's practically pre-Copernican approach to important policy decisions.... The book is sprinkled liberally with sentences that are thought-provoking gems, each worthy of an essay of its own.... [A] very rich book." -- National Review "Our ability to read the genetic code heralds a transformation of modern medicine. Yet many potential medical miracles remain throttled....[Huber's] ardor for invigorating pharmaceutical progress is apparent on every page." -- Booklist "Intriguing." -- Kirkus Reviews "A provocative, optimistic look at modern medicine... Huber's challenge is sure to spark controversy as the U.S. adapts to the Affordable Care Act." -- Publishers Weekly "A must read for physicians, patients, biotech investors, and healthcare politicians, The Cure in the Code is the most important policy book of the decade, and it could only have been written by Peter Huber, a polymathic master of both the deadly menace and huge promise of bioscience, and scathing critic of the blindness of healthcare bureaucracy." -- George Gilder, author of Knowledge and Power: The Information Theory of Capitalism "A thoughtful and compelling account of how the federal government's current regulatory science is not only outdated, but risks hampering scientific efforts to combat diseases at the molecular level. Marshaling insights from medicine, law, and economics, Huber makes an urgent case for how to improve the drug and therapy regulatory system to better equip physicians with innovative treatments that meet critical patient needs." -- Tom Coburn, M.D., United States Senator from Oklahoma "Peter Huber is one of only a handful of public intellectuals with a deep understanding of science, economics, and the law. In The Cure in the Code , Huber explains scientific advances in molecular biology and genetic engineering, the economics of pharmaceuticals and medicine, and the intersection of all of these with FDA law and policy. This is a key guide to the promise of personalized medicine--personalized down to the genetic level--and also to the policies that can deliver that promise." -- Alex Tabarrok, Professor and Bartley J. Madden Chair in Economics, George Mason University "Peter Huber has eloquently portrayed the transition of medicine from art to science in the 21st century. But The Cure in the Code offers much more as he illuminates the changes that must occur in the research, regulatory, reimbursement ecosystem if the promise of cures is to be fulfilled." -- Andrew von Eschenbach, Commissioner of the U.S. Food and Drug Administration (2005-2009), "A must read for physicians, patients, biotech investors, and healthcare politicians, The Cure in the Code is the most important policy book of the decade, and it could only have been written by Peter Huber, a polymathic master of both the deadly menace and huge promise of bioscience, and scathing critic of the blindness of healthcare bureaucracy." -- George Gilder, author of Knowledge and Power: The Information Theory of Capitalism "A thoughtful and compelling account of how the federal government's current regulatory science is not only outdated, but risks hampering scientific efforts to combat diseases at the molecular level. Marshaling insights from medicine, law, and economics, Huber makes an urgent case for how to improve the drug and therapy regulatory system to better equip physicians with innovative treatments that meet critical patient needs." -- Tom Coburn, M.D., United States Senator from Oklahoma, [An] urgent, compelling account of how 21st-century medicine is being hampered by a regulatory regime built for the science of the 20th century." — Wall Street Journal [An] exciting and authoritative review of accelerating advances in personalized medicine." — Barron's Spotlighting an area where federal laws and regulations lag far behind technological innovation, the author, a Manhattan Institute senior fellow, maintains that medicine's rapidly developing capacity to decode individual human genomes and tailor patients' treatments accordingly – as with breast cancer – is being hindered by...‘outdated drug-approval protocols developed decades ago during medicine's long battle with the infectious epidemics of the past.'" — Pittsburgh Tribune-Review [Huber is] one of the few men walking the Earth who could write a book about FDA reform that is not only profitable but pleasurable to read. The book is exciting, in that it suggests possibilities for significant improvements in our ability to treat terrifying diseases in the near future; but it is also depressing, because its sophisticated analysis – in flying so far above regulation-deregulation and government-market binaries that dominate so many of our policy debates – cannot help but draw one's attention to the intellectual poverty of Washington's practically pre-Copernican approach to important policy decisions.... The book is sprinkled liberally with sentences that are thought-provoking gems, each worthy of an essay of its own.... [A] very rich book." — National Review Our ability to read the genetic code heralds a transformation of modern medicine. Yet many potential medical miracles remain throttled….[Huber's] ardor for invigorating pharmaceutical progress is apparent on every page." — Booklist Intriguing." — Kirkus Reviews A provocative, optimistic look at modern medicine… Huber's challenge is sure to spark controversy as the U.S. adapts to the Affordable Care Act." — Publishers Weekly A must read for physicians, patients, biotech investors, and healthcare politicians, The Cure in the Code is the most important policy book of the decade, and it could only have been written by Peter Huber, a polymathic master of both the deadly menace and huge promise of bioscience, and scathing critic of the blindness of healthcare bureaucracy." — George Gilder, author of Knowledge and Power: The Information Theory of Capitalism A thoughtful and compelling account of how the federal government's current regulatory science is not only outdated, but risks hampering scientific efforts to combat diseases at the molecular level. Marshaling insights from medicine, law, and economics, Huber makes an urgent case for how to improve the drug and therapy regulatory system to better equip physicians with innovative treatments that meet critical patient needs." — Tom Coburn, M.D., United States Senator from Oklahoma Peter Huber is one of only a handful of public intellectuals with a deep understanding of science, economics, and the law. In The Cure in the Code , Huber explains scientific advances in molecular biology and genetic engineering, the economics of pharmaceuticals and medicine, and the intersection of all of these with FDA law and policy. This is a key guide to the promise of personalized medicine—personalized down to the genetic level—and also to the policies that can deliver that promise." — Alex Tabarrok, Professor and Bartley J. Madden Chair in Economics, George Mason University Peter Huber has eloquently portrayed the transition of medicine from art to science in the 21st century. But The Cure in the Code offers much more as he illuminates the changes that must occur in the research, regulatory, reimbursement ecosystem if the promise of cures is to be fulfilled." — Andrew von Eschenbach, Commissioner of the U.S. Food and Drug Administration (2005-2009), "A provocative, optimistic look at modern medicine... Huber's challenge is sure to spark controversy as the U.S. adapts to the Affordable Care Act." -- Publishers Weekly "A must read for physicians, patients, biotech investors, and healthcare politicians, The Cure in the Code is the most important policy book of the decade, and it could only have been written by Peter Huber, a polymathic master of both the deadly menace and huge promise of bioscience, and scathing critic of the blindness of healthcare bureaucracy." -- George Gilder, author of Knowledge and Power: The Information Theory of Capitalism "A thoughtful and compelling account of how the federal government's current regulatory science is not only outdated, but risks hampering scientific efforts to combat diseases at the molecular level. Marshaling insights from medicine, law, and economics, Huber makes an urgent case for how to improve the drug and therapy regulatory system to better equip physicians with innovative treatments that meet critical patient needs." -- Tom Coburn, M.D., United States Senator from Oklahoma "Peter Huber is one of only a handful of public intellectuals with a deep understanding of science, economics, and the law. In The Cure in the Code , Huber explains scientific advances in molecular biology and genetic engineering, the economics of pharmaceuticals and medicine, and the intersection of all of these with FDA law and policy. This is a key guide to the promise of personalized medicine--personalized down to the genetic level--and also to the policies that can deliver that promise." -- Alex Tabarrok, Professor and Bartley J. Madden Chair in Economics, George Mason University "Peter Huber has eloquently portrayed the transition of medicine from art to science in the 21st century. But The Cure in the Code offers much more as he illuminates the changes that must occur in the research, regulatory, reimbursement ecosystem if the promise of cures is to be fulfilled." -- Andrew von Eschenbach, Commissioner of the U.S. Food and Drug Administration (2005-2009), "Intriguing." -- Kirkus Reviews "A provocative, optimistic look at modern medicine... Huber's challenge is sure to spark controversy as the U.S. adapts to the Affordable Care Act." -- Publishers Weekly "A must read for physicians, patients, biotech investors, and healthcare politicians, The Cure in the Code is the most important policy book of the decade, and it could only have been written by Peter Huber, a polymathic master of both the deadly menace and huge promise of bioscience, and scathing critic of the blindness of healthcare bureaucracy." -- George Gilder, author of Knowledge and Power: The Information Theory of Capitalism "A thoughtful and compelling account of how the federal government's current regulatory science is not only outdated, but risks hampering scientific efforts to combat diseases at the molecular level. Marshaling insights from medicine, law, and economics, Huber makes an urgent case for how to improve the drug and therapy regulatory system to better equip physicians with innovative treatments that meet critical patient needs." -- Tom Coburn, M.D., United States Senator from Oklahoma "Peter Huber is one of only a handful of public intellectuals with a deep understanding of science, economics, and the law. In The Cure in the Code , Huber explains scientific advances in molecular biology and genetic engineering, the economics of pharmaceuticals and medicine, and the intersection of all of these with FDA law and policy. This is a key guide to the promise of personalized medicine--personalized down to the genetic level--and also to the policies that can deliver that promise." -- Alex Tabarrok, Professor and Bartley J. Madden Chair in Economics, George Mason University "Peter Huber has eloquently portrayed the transition of medicine from art to science in the 21st century. But The Cure in the Code offers much more as he illuminates the changes that must occur in the research, regulatory, reimbursement ecosystem if the promise of cures is to be fulfilled." -- Andrew von Eschenbach, Commissioner of the U.S. Food and Drug Administration (2005-2009), "Intriguing." — Kirkus Reviews A provocative, optimistic look at modern medicine… Huber's challenge is sure to spark controversy as the U.S. adapts to the Affordable Care Act." — Publishers Weekly A must read for physicians, patients, biotech investors, and healthcare politicians, The Cure in the Code is the most important policy book of the decade, and it could only have been written by Peter Huber, a polymathic master of both the deadly menace and huge promise of bioscience, and scathing critic of the blindness of healthcare bureaucracy." — George Gilder, author of Knowledge and Power: The Information Theory of Capitalism A thoughtful and compelling account of how the federal government's current regulatory science is not only outdated, but risks hampering scientific efforts to combat diseases at the molecular level. Marshaling insights from medicine, law, and economics, Huber makes an urgent case for how to improve the drug and therapy regulatory system to better equip physicians with innovative treatments that meet critical patient needs." — Tom Coburn, M.D., United States Senator from Oklahoma Peter Huber is one of only a handful of public intellectuals with a deep understanding of science, economics, and the law. In The Cure in the Code , Huber explains scientific advances in molecular biology and genetic engineering, the economics of pharmaceuticals and medicine, and the intersection of all of these with FDA law and policy. This is a key guide to the promise of personalized medicine—personalized down to the genetic level—and also to the policies that can deliver that promise." — Alex Tabarrok, Professor and Bartley J. Madden Chair in Economics, George Mason University Peter Huber has eloquently portrayed the transition of medicine from art to science in the 21st century. But The Cure in the Code offers much more as he illuminates the changes that must occur in the research, regulatory, reimbursement ecosystem if the promise of cures is to be fulfilled." — Andrew von Eschenbach, Commissioner of the U.S. Food and Drug Administration (2005-2009)
Copyright Date
2013
Lccn
2013-026302
Dewey Decimal
338.476153
Intended Audience
Trade
Dewey Edition
23
Illustrated
Yes
Item description from the seller
Seller assumes all responsibility for this listing.
eBay item number:256436568841
Shipping and handling
Item location:
Montgomery, Illinois, United States
Ships to:
Canada, Mexico, United States
Excludes:
Africa, Asia, Barbados, Bermuda, Central America and Caribbean, Europe, French Guiana, French Polynesia, Greenland, Guadeloupe, Libya, Martinique, Middle East, New Caledonia, Oceania, Reunion, Russian Federation, Saint Pierre and Miquelon, South America, Southeast Asia, Ukraine, Venezuela
| Shipping and handling | Each additional item | To | Service | Delivery*See Delivery notes |
|---|---|---|---|---|
| Free shipping | Free | United States | Economy Shipping (USPS Media MailTM) | Estimated between Thu, May 9 and Tue, May 14 to 43230 |
| US $4.95 (approx C $6.79) | US $4.95 (approx C $6.79) | United States | Standard Shipping (DGM SmartMail Expedited) | Estimated between Mon, May 13 and Fri, May 17 to 43230 |
| US $10.95 (approx C $15.01) | US $10.95 (approx C $15.01) | United States | Expedited Shipping (FedEx 2Day®) | Estimated between Tue, May 7 and Wed, May 8 to 43230 |
| Handling time |
|---|
| Will usually ship within 1 business day of receiving cleared payment. |
| Taxes |
|---|
| Seller charges sales tax in |
Sales tax for an item #256436568841
Sales tax for an item #256436568841
Seller collects sales tax for items shipped to the following provinces:
| Province | Sales Tax Rate |
|---|
Return policy
| After receiving the item, contact seller within | Refund will be given as |
|---|---|
| 30 days after the buyer receives it | Money Back |
The seller is responsible for return shipping costs.
Payment details
Payment methods
Popular categories from this store
Seller feedback (5,840,514)
z***z (600)- Feedback left by buyer.
Past month
Verified purchase
🏆 SUPER STAR 🤩 AMAZING PHOTOS 🎯 ACCURATE DESCRIPTION ✏️ GENUINE PRODUCTS 💎 HIGH QUALITY 🍯 SUPER PRICES 💰 EASY TO WORK WITH 🍰 ECONOMY HANDLING ⏱️ FAST SHIPPING 🚀 BUBBLE PACKAGE 📦 ARRIVED WITHIN DAYS 🌎 EXCEPTIONAL COMMUNICATION 🎙️ OUTSTANDING CUSTOMER SERVICE 🛎️ GREAT SENSE OF HUMOR 🍿 TOTAL ASSET TO THE EBAY-ECO SYSTEM 🥇 SAVED SELLER 🎱 PROMT REPLY FOR RETURNS 🎯 WOULD BUY FROM AGAIN 🧲 UNDER PROMISES OVER DELIVERS ⛳️ MADE ME VERY HAPPY 🌈 LEFT POSITIVE FEEDBACK 🌼 THANK YOU! 😇 A+++
n***e (400)- Feedback left by buyer.
Past 6 months
Verified purchase
This item didn’t come in exactly as pictured, but the seller responded immediately and was very gracious in offering me a partial refund even bough I wasn’t expecting one for what I paid for the item. I have bought from this seller before, and they are reputable and stand behind the products they sell. My other transactions with them have been perfect. Great communication. Packaging and price were good. Fairly fast shipping, too. Thanks.
e***r (2638)- Feedback left by buyer.
Past 6 months
Verified purchase
This item came in exactly as pictured, and the seller posted immediately and was very gracious. I didn't ask for a partial refund. Why would I? I bought what I was expecting and received what I paid for the item. Not sure if I have bought from this seller before, but they are reputable and stand behind the products they sell. My future transactions with them will no doubt be perfect. Great communication. Packaging and price were good. Fairly fast shipping, too. Thanks.
Product ratings and reviews
More to explore:
- Law Textbooks,
- Law Textbook Textbooks,
- Constitutional Law Textbooks,
- Law Textbooks in English,
- Law Paperback Textbooks,
- Law Nonfiction Fiction & Nonfiction Books,
- Law Study Guides & Test Prep,
- Law Nonfiction Books Fiction & Nonfiction Books,
- Ex-Library Law Textbooks,
- Law & Government Sets Antiquarian & Collectible Books